GUJTHEM

Gujarat Themis Biosyn vs Peers

₹379.50-2.69%
Market cap
₹4,135 crore
P/E
84.9
P/B
14.37
ROE
17.4%
Dividend yield
0.18%

Gujarat Themis Biosyn ranks 52nd by market capitalisation among 71 Pharmaceuticals companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E of 84.9 compares with a peer median of 33.6.

Gujarat Themis Biosyn vs Pharmaceuticals peers

Sorted by market capitalisation.

Gujarat Themis Biosyn and peers compared on size, valuation and returns
CompanyClose (₹)1DMarket cap (₹ cr)P/EP/BROE1Y return
Sun Pharmaceutical Industries1,773.60-1.69%4,25,54635.25.0914.7%+12.5%
Divi's Laboratories9,586.00+0.38%2,54,47887.015.1816.2%+12.5%
Torrent Pharmaceuticals4,693.90-1.64%1,58,86372.818.9427.1%+12.5%
Zydus Lifesciences1,151.30-0.71%1,15,84825.74.2719.7%+12.5%
Laurus Labs2,052.90+0.14%1,10,827101.420.9118.2%+12.5%
Cipla1,333.00-0.54%1,07,67732.03.1311.8%+12.5%
Mankind Pharma2,496.00-0.16%1,03,04250.46.3212.5%+12.5%
Dr. Reddy's Laboratories1,194.90-1.08%99,53330.12.6012.1%+12.5%
Aurobindo Pharma1,677.90-0.88%97,45326.32.579.9%+12.5%
Lupin2,006.70-1.11%91,74216.64.0926.9%+12.5%
Gujarat Themis Biosyn379.50-2.69%4,13584.914.3717.4%—

Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.

Gujarat Themis Biosyn peer comparison — frequently asked questions

Who are Gujarat Themis Biosyn's competitors?

Gujarat Themis Biosyn's listed peers in Pharmaceuticals include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs and Cipla, ranked here by market capitalisation.

How does Gujarat Themis Biosyn's P/E compare with its peers?

Gujarat Themis Biosyn trades at a P/E of 84.9, against a median of 33.6 across the 10 Pharmaceuticals peers shown.

Which is the largest company among Gujarat Themis Biosyn's peers?

By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹4,135 crore for Gujarat Themis Biosyn.

Same Data For Peers

Trade Gujarat Themis Biosyn With ATS

Track GUJTHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.